How Much Does ARA-290 Cost in 2026? Pricing Breakdown

Key Takeaways

• ARA-290 is not FDA-approved and is available only for research purposes, impacting its cost and accessibility.
• Patients typically pay out of pocket, as insurance coverage is rare for non-FDA-approved peptides.
• Telehealth services may offer bundled pricing for consultations and medications, potentially reducing costs.
• Manufacturer savings programs and discount tools like GoodRx can help lower expenses for eligible therapies.

What Is ARA-290?

ARA-290 is a synthetic research peptide derived from the B-helix domain of erythropoietin. It is designed to bind to the EPOR–CD131 receptor complex, activating the IRR pathway without stimulating erythropoiesis, which is primarily studied for its anti-inflammatory and tissue-protective properties. For more detailed information, visit the full profile.

Typical Cost Ranges

As of 2026, ARA-290 remains a research-only peptide and is not legally available for therapeutic use in the United States. Consequently, specific cost information for therapeutic applications is not applicable. However, for research purposes, the cost of ARA-290 can vary significantly based on the supplier and the quantity purchased. Prices can range from $100 to $500 for small quantities of lyophilized powder. These prices reflect research-grade material and not a therapeutic product.

Insurance Coverage

Due to its status as a research-only peptide, ARA-290 is generally not covered by insurance plans. Insurance providers typically require FDA approval before offering coverage, and non-FDA-approved peptides like ARA-290 are excluded from most benefit plans. Patients interested in peptides with FDA approval may have better insurance coverage options.

HSA/FSA Eligibility

Since ARA-290 is not approved for therapeutic use, it is unlikely to qualify for Health Savings Account (HSA) or Flexible Spending Account (FSA) spending. These accounts generally cover FDA-approved treatments and medications prescribed by a licensed healthcare provider.

Telehealth vs. In-Person Pricing

Telehealth services often provide a bundled pricing model that includes consultations and medications, potentially offering cost savings compared to traditional in-person clinic visits. However, given ARA-290's research-only status, telehealth services do not typically offer this peptide for therapeutic purposes. For peptides that are available through telehealth, patients may find reduced costs through monthly subscription models.

Ways to Reduce Cost

While ARA-290 is not available for therapeutic use, those interested in other peptides can explore several cost-reduction strategies:

• Manufacturer Savings Programs: Some pharmaceutical companies offer savings programs for eligible peptides.
• Compounding Pharmacies: If legal, compounding pharmacies may offer more affordable options.
• Patient Assistance Programs: These programs can provide financial assistance to eligible patients.
• Discount Tools: Platforms like GoodRx can offer discounts on medications when applicable.

Cost Compared to Alternatives

For those seeking alternatives with similar therapeutic goals, peptides like BPC-157 and TB-500 are often considered. Both are used for tissue repair and inflammation management, though their costs and regulatory statuses differ. BPC-157 and TB-500 are also not FDA-approved, but they may be more accessible through compounding pharmacies.

What to Ask Your Provider About Cost

• Is ARA-290 available for therapeutic use, or is it strictly for research?
• Are there alternative peptides that are more cost-effective and accessible?
• What are the expected costs for consultations and medications through your clinic?
• Are there any patient assistance programs or discounts available for peptides?

FAQ

What is the typical cost of ARA-290? ARA-290 is not available for therapeutic use, so specific cost information for therapy is not applicable. Research-grade material can range from $100 to $500.

Does insurance cover ARA-290? No, insurance typically does not cover ARA-290 as it is not FDA-approved and is only available for research purposes.

Can I use HSA/FSA funds for ARA-290? ARA-290 is unlikely to qualify for HSA/FSA spending due to its research-only status.

Are there ways to reduce the cost of other peptides? Yes, manufacturer savings programs, compounding pharmacies, patient assistance programs, and discount tools like GoodRx may help reduce costs for other peptides.

What should I ask my provider about peptide therapy costs? Inquire about the availability of the peptide, alternative options, expected costs, and any available financial assistance programs.

---

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any treatment.